*Shota Arakawa^1,2, Hata Junichi¹, Keiya Kandori¹, Miyu Okazaki¹, Yuichi Suzuki², Toshihiro Hayashi², Osamu Abe² (1. Department of Radiological Sciences, Graduate School of Human Health Sciences, Tokyo Metropolitan University)

*Tomoaki Fukami¹, ryutaro yano¹, syuhei takemoto¹, yuichi yamashita¹ (1. CANON MEDICAL SYSTEMS CORPORATION, MRI Sales department)

*Shiori Sugahara¹, Atsushi Kumakyu¹, Toshihiro Nishino¹ (1. Department of Radiology, National Hospital Organization Osaka Medical Center)

*Yuichiro Somiya¹, Takahiro Tsuboyama², Shintaro Horii¹, Naoki Yoshida¹, Ryuji Shimada³, Keitaro Sofue², Akiko Kusaka¹, Takamichi Murakami² (1. Center for Radiology Radiation Oncology, Kobe University Hospital, 2. Department of Radiology, Kobe University, 3. Department of Radiological Technology, Faculty of Health Science kobe Tokiwa University)

*Ayano Oku^1,2, Kanako Muta^1,2, Junichi Hata^1,2,3, Noriyuki Kishi², Taeko Ito², Naoya Hayashi^1,2, Hinako Oshiro^1,2, Ayane Ishida^1,2, Hideyuki Okano^2,3 (1. Department of Radiological Sciences, Graduate School of Humanities, Tokyo Metropolitan University)

*Yoshitaka Masutani¹, Yuki Ichinoseki¹, Kousei Konya¹ (1. Department of Medical Image Computation, Tohoku University Graduate School of Medicine)

*Matthew Nielsen¹, Masayuki Yamaguchi², Yoshihisa Muramatsu², Hiroshi Kusahara¹, Yutaka Machii¹, Mitsuki Akatsuka², Asao Ogawa^3,4, Hitoshi Kanazawa¹, Tatsushi Kobayashi² (1. Canon Medical Systems Corporation, 2. Department of Diagnostic Radiology, National Cancer Center Hospital East, Japan, 3. Department of Psycho-Oncology Service, National Cancer Center Hospital East, Japan, 4. Division of Psycho-Oncology, National Cancer Center Exploratory Oncology Research & Clinical Trial Center (EPOC), Japan)